• MPC, Lactate, and Histone Lactylation in CRC

  2026-08-23

  The reference study identifies a metabolic–epigenetic–immune pathway in colorectal cancer in which reduced MPC1/MPC2 activity increases lactate, elevates histone lactylation in dendritic cells, and weakens CD8+ T-cell responses. Its findings position MPC as a potential regulator of tumor progression and anti-PD-1 efficacy, while also providing a framework for studying lactate-dependent immune regulation.

• Cisplatin Workflows for Platinum-Resistance Studies

  2026-08-22

  Cisplatin (CDDP) provides a mechanistic benchmark for linking DNA crosslinking with apoptosis, oxidative stress, and platinum resistance. This workflow-oriented guide shows how to move from cell viability and apoptosis assays to xenograft studies while testing the CLK2–BRCA1 repair axis described in ovarian cancer research.

• Senescence Signatures in Abdominal Aortic Aneurysm

  2026-08-22

  This study combines transcriptomic analysis, machine learning, single-cell RNA sequencing, and experimental validation to identify senescence-related biomarkers associated with abdominal aortic aneurysm. ETS1 and ITPR3 emerged as the most consistent candidates, providing a foundation for earlier molecular detection while highlighting the need for prospective and mechanistic validation.

• Annexin-V Maps Cardiomyocyte Death After Cardiac I/R

  2026-08-21

  The reference study established labeled recombinant human annexin-V as an in situ method for detecting early cardiomyocyte death after myocardial ischemia and reperfusion. By resolving the timing of phosphatidylserine exposure in living mice, it provided a practical readout for evaluating interventions intended to limit ischemia/reperfusion-associated cell loss.

• Sulfachloropyridazine Research Workflows

  2026-08-20

  Sulfachloropyridazine connects DHPS-focused enzyme inhibition assays with antimicrobial susceptibility testing and microbiome-aware infection research. This workflow shows how to improve solubility control, interpret combination effects, and translate cecal microbiota findings into stronger experimental designs.

• Tankyrase Inhibition and the Hippo Cascade in HCC

  2026-08-20

  The reference study shows that XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity and increasing the YAP inhibitors AMOTL1 and AMOTL2. Its main contribution is to connect tankyrase inhibition with Hippo-pathway regulation, providing a mechanistic basis for combining tankyrase inhibitors with MEK or AKT pathway inhibitors.

• RepSox in hiPSC Platelet Differentiation Design

  2026-08-19

  RepSox is a potent ALK5 inhibitor for dissecting how TGF-β signaling influences hiPSC reprogramming and megakaryocyte maturation. This article connects a 2026 platelet-production study with a mechanistic, checkpoint-based assay strategy while separating validated findings from testable RepSox hypotheses.

• Carrier-Platin Triggers a Rapid ROS Storm in Cancer

  2026-08-19

  The reference study introduces carrier-platin, a platinum-based nanotherapeutic that confines ultrasmall platinum nanoparticles within a poly(amino acid) carrier to catalyze rapid intracellular ROS accumulation. Its reported cancer-killing activity occurs independently of DNA damage and differs from both apoptosis and ferroptosis, suggesting a distinct strategy for addressing drug-resistant tumors.

• Actinomycin D in LUAD: From Transcription to Translation

  2026-08-18

  Actinomycin D can serve as more than a cytotoxic reagent: it is a mechanistic stress test for connecting transcriptional control, mRNA persistence, and metastatic plasticity in lung adenocarcinoma. This article translates findings from the IGF2BP3/MCM5/Notch axis into a practical, evidence-aware workflow for mRNA stability, apoptosis induction, and translational model design.

• SAR131675: VEGFR-3 Inhibitor Workflow Guide

  2026-08-18

  SAR131675 enables selective interrogation of VEGFR-3-driven lymphatic endothelial survival, migration, and vascular remodeling. This workflow guide translates its nanomolar biochemical and cellular activity into practical assay design while separating validated anti-lymphangiogenic use-cases from exploratory kidney-disease applications.

• Clodronate Liposomes for In Vivo Macrophage Depletion

  2026-08-17

  Clodronate Liposomes provide phagocytosis-mediated delivery of liposome-encapsulated clodronate for experimental in vivo macrophage depletion. K2721 supports route- and tissue-specific macrophage perturbation, but depletion should not be interpreted as equivalent to CCL7 blockade or macrophage-specific genetic ablation.

• Actinomycin D Workflows for RNA Stability

  2026-08-17

  Actinomycin D converts transcriptional inhibition into a practical tool for mRNA decay, apoptosis induction, and transcriptional stress studies. This guide also shows how ActD can complement the circCHSY1–miR-24-3p–HO1 findings in myocardial ischaemia/reperfusion research without confusing a broad transcriptional perturbation with a gene-specific mechanism.

• Proteinase K: From DNA Prep to Assay Strategy

  2026-08-16

  Proteinase K is more than a routine digestion reagent: its substrate preference, inhibitor resilience, and compatibility with demanding buffers make it a strategic control point in genomic DNA workflows and protease assays. This article connects those properties to translational experimental design while defining what the evidence does—and does not—support.

• Hesperadin: Aurora B Kinase Inhibitor Workflows

  2026-08-15

  Hesperadin is an Aurora B kinase inhibitor for separating kinase-driven mitotic defects from broader cytotoxic effects. This practical guide covers assay setup, checkpoint-focused workflows, quantitative readouts, and troubleshooting for cell cycle and cancer research.

• Enhanced ECL Detection Kit for Gut–Tumor Biology

  2026-08-14

  The Enhanced ECL detection kit supports sensitive western blot analysis of the protein pathways connecting gut microbial metabolism with breast cancer progression. This article translates the Prevotella copri–IPyA–UHRF1–AMPK findings into a rigorous, decision-oriented protein immunodetection workflow.

7883 records 1/526 page Next 12345 下5页 Last page